Sign Out
Rabeprazole sodium (Reloxa) tablets are indicated for the treatment of: Active duodenal ulcer.
Active benign gastric ulcer.
Symptomatic erosive or ulcerative gastroesophageal reflux disease (GERD).
H. pylori-positive duodenal ulcers, as part of the eradication programme with appropriate antibiotics.
Maintenance treatment of healed erosive or ulcerative GERD.
Efficacy has not been demonstrated for periods exceeding 12 months.
Continue with Google